LT - PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERS
EN - PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/445 |
(2006.01) |
|
|
A61P 25/00 |
(2018.01) |
|
|
A61K 31/4985 |
(2006.01) |
|
|
A61K 31/4985 |
(2013.01) |
|
|
A61P 25/00 |
(2006.01) |
|
|
A61K 31/445 |
(2013.01) |
European patent
| (11) |
Number of the document |
3838274 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
20215786.3 |
|
Date of filing the European patent application |
2017-01-26 |
| (97) |
Date of publication of the European application |
2021-06-23 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-11-01
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201662287264 P |
2016-01-26
|
US |
|
201662440130 P |
2016-12-29
|
US |
Inventors
| (72) |
LI, Peng , US
YAO, Wei , US
|
Grantee
| (73) |
Intra-Cellular Therapies, Inc. ,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
Title
| (54) |
PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERS |
| |
PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERS |